The Liver Week 2026

PROGRAM

Turning Evidence into New Standards inLiver Disease Care

June 11-13, 2026ICONRAD, Seoul, Korea

PROGRAM AT A GLANCE DAILY PROGRAM INVITED FACULTY MEAL PLAN INDUSTRY SYMPOSIA

*K: Session in Korean

09:00-10:40

PG Course 1 (*K)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Viral Hepatitis (HBV, HCV, HDV, HEV), Primary Biliary Cholangitis, and Autoimmune Hepatitis

Chair: Moon Seok Choi (Sungkyunkwan Univ.), Yoon Jun Kim (Seoul National Univ.)

  • 09:00-09:25

  • Practical Use of GLP-1 Receptor Agonists in MASLD: Dosing, Patient Counseling, and Safety Considerations

    Han Ah Lee (Chung-Ang Univ.)

  • 09:25-09:50

  • Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Biliary Cholangitis in Clinical Practice

    Kyung-Ah Kim (Inje Univ.)

  • 09:50-10:15

  • Optimizing HCV Management in Real-World Practice

    Yang Hyun Baek (Dong-A Univ.)

  • 10:15-10:40

  • HBV-HDV Coinfection: Diagnosis, Natural Course, and Clinical Pitfalls

    Jeong Won Jang (The Catholic Univ. of Korea)

  • 10:40-10:55

  • Coffee Break

10:55-12:15

PG Course 2 (*K)
Hepatocellular Carcinoma (HCC), Portal Hypertension, and Alcohol-Related Liver Disease

Chair: Young Seok Kim (Soonchunhyang Univ.), Jin-Woo Lee (Inha Univ.)

  • 10:55-11:15

  • Diagnosis and Non-Invasive Assessment of Portal Hypertension

    Seung Up Kim (Yonsei Univ.)

  • 11:15-11:35

  • TIPS: Selecting the Right Patient with Portal Hypertension

    Yeon Seok Seo (Korea Univ.)

  • 11:35-11:55

  • Alcohol-Related Liver Disease: From Assessment to Management

    Young Kul Jung (Korea Univ.)

  • 11:55-12:15

  • Systemic Therapy for HCC: First-Line, Second-Line, and Beyond

    Ju Hyun Shim (Univ. of Ulsan)

  • 12:15-13:15

  • Luncheon Symposium 1

13:15-13:55

2026 KASL Clinical Practice Guidelines: Liver Cirrhosis (*K)

Chair: Jae Young Jang (Soonchunhyang Univ.)

  • 13:15-13:55

  • 2026 KASL Clinical Practice Guidelines: Liver Cirrhosis

    Moon Young Kim (Yonsei Univ. Wonju)

13:55-15:35

PG Course 3
Chronic Hepatitis B (*K)

Chairs: Byung-Cheol Song (Jeju National Univ.), Young Oh Kweon (Kyungpook National Univ.)

  • 13:55-14:20

  • Updated KASL Guidelines on Chronic Hepatitis B

    Won-Mook Choi (Univ. of Ulsan)

  • 14:20-14:45

  • Treatment Strategy for Chronic Hepatitis B: Who, When, and What Goals to Achieve?

    Nae-Yun Heo (Inje Univ.)

  • 14:45-15:10

  • Assessing Disease Activity and Fibrosis in Chronic Hepatitis B: Non-Invasive Techniques and Beyond

    Beom Kyung Kim (Yonsei Univ.)

  • 15:10-15:35

  • Interactions between HBV and Coexisting Liver Diseases: Clinical Implications in HCV and MASLD

    Ki Tae Yoon (Pusan National Univ.)

  • 15:35-15:50

  • Coffee Break

15:50-17:10

PG Course 4
Chronic Hepatitis B

Chair: Ming-Lung Yu (Kaohsiung Medical Univ., Taiwan), Won Young Tak (Kyungpook National Univ.)

  • 15:50-16:10

  • Revisiting the Natural Course of Chronic Hepatitis B: Implications of the Indeterminate Phase

    Tetsuo Takehara (Osaka Univ., Japan)

  • 16:10-16:30

  • Risk Stratification and Surveillance Strategies for HCC in Chronic Hepatitis B

    Ju Dong Yang (Cedars-Sinai Medical Center, USA)

  • 16:30-16:50

  • Clinical Course and Management Considerations after Antiviral Therapy Discontinuation in Chronic Hepatitis B

    Tung-Hung Su (National Taiwan Univ., Taiwan)

  • 16:50-17:10

  • Innovative Therapeutic Strategies for Functional Cure in HBV

    Edward Gane (Univ. of Auckland, New Zealand)

09:00-10:40

Basic Research Workshop 1 (*K)
Viral Load-Based Immune Landscapes in Chronic Hepatitis B: From Tolerance to Cure

Chair: Kyun-Hwan Kim (Sungkyunkwan Univ.), Hyung Joon Yim (Korea Univ.)

  • 09:00-09:25

  • Immune Dysfunction in Chronic Hepatitis B: Innate and Adaptive Perspectives

    Su-Hyung Park (KAIST)

  • 09:25-09:50

  • Untreated Chronic HBV: Viremia-Dependent Immune States

    Sung-Gyoo Park (Seoul National Univ.)

  • 09:50-10:15

  • Immune Modulation Mechanisms during Antiviral Therapy

    Pil Soo Sung (The Catholic Univ. of Korea)

  • 10:15-10:40

  • Functional Cure: Mechanisms of Sustained Immune Control

    Eui-Cheol Shin (KAIST)

  • 10:40-10:55

  • Coffee Break

10:55-12:15

Basic Research Workshop 2 (*K)
Basic and Translational Research Methodologies in HBV Studies

Chair: Eui-Cheol Shin (KAIST), Jeong Won Jang (The Catholic Univ. of Korea)

  • 10:55-11:15

  • Molecular Techniques for Analyzing HBV Replication and cccDNA Transcriptional Activity

    Kyun-Hwan Kim (Sungkyunkwan Univ.)

  • 11:15-11:35

  • Cell Culture, in vitro, and Animal Models

    Heeju Ryu (Sungkyunkwan Univ.)

  • 11:35-11:55

  • Immune Response Measurement Using Human Samples

    Seunghee Hong (Yonsei Univ.)

  • 11:55-12:15

  • High-Dimensional and Multi-Omics Approaches in HBV Research

    Su Bin Lim (Ajou Univ.)

  • 12:15-13:15

  • Luncheon Symposium 2

13:55-15:35

Career Development for Young Investigators (*K)
Beyond the White Coat: Diverse Journeys in Modern Medicine

Chair: So Young Kwon (Konkuk Univ.), Hyung Joon Kim (Chung-Ang Univ.)

  • 13:55-14:20

  • The Journey of a Physician-Scientist: Bridging the Bench and the Bedside

    Hyung Jin Choi (Seoul National Univ.)

  • 14:20-14:45

  • From Idea to Impact: The Doctor as an Entrepreneur

    Jeong Seok Lee (KAIST)

  • 14:45-15:10

  • The Nature of Medicine as a Servant

    Chang Wook Kim (The Catholic Univ. of Korea)

  • 15:10-15:35

  • On the Frontline of Digital Health: Redefining the Future of Care

    Min Kyu Han (Kakao Healthcare)